MedTech Dive

Microbot receives 510(k) clearance for endovascular robot

The company will now complete final commercial activities in preparation for targeting the 2.5 million peripheral vascular ...
FierceBiotech

Microbot Medical clears pivotal study for remote-controlled endovascular procedures

With its remote endovascular procedure system currently under review at the FDA, Microbot Medical has put forward positive results from a pivotal study touting a 100% satisfaction rate among ...
Nasdaq

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

Baptist Hospital of Miami is the second site to perform clinical procedures as part of the Company’s Pivotal Human Clinical Trial. The clinical trial is expected to support the future submission to ...
MassDevice

FDA clears Microbot Medical’s Liberty endovascular surgical robot

Clearance makes Liberty the first FDA-cleared single-use, remotely operated robotic system for peripheral endovascular ...

Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System

Accelerated Launch Readiness Plans Position Company for Commercialization during Q4 2025The Company’s Initial Addressable Market Includes ...
FierceBiotech

Microbot Medical scores FDA clearance for remote-controlled cath lab system

Microbot Medical has received the FDA’s blessing for its miniature, remote-controlled robot for endovascular procedures, designed to offer clinicians the freedom to sit comfortably and operate outside ...
Morningstar

Microbot Medical® Strengthens Its Commercial Capabilities with the Addition of David J. Wilson to the Board of Directors

BRAINTREE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, is continuing its transition into a ...